US2019282816A1PendingUtilityA1
Methods and apparatus for renal neuromodulation
Assignee: MEDTRONIC ADRIAN LUXEMBOURG S A R LPriority: Apr 8, 2002Filed: Mar 28, 2019Published: Sep 19, 2019
Est. expiryApr 8, 2022(expired)· nominal 20-yr term from priority
Inventors:Mark DeemDenise ZarinsDouglas SuttonHanson S. Gifford, IiiHoward R. LevinMark GelfandBenjamin J. Clark
A61N 1/36128A61B 2018/1435A61B 2018/00982A61N 1/327A61B 2018/00404A61N 1/32A61B 2018/00613A61B 2018/00511A61N 1/36007A61B 2018/00791A61B 18/1492A61B 2018/00434A61N 1/36017A61N 1/0551A61B 2018/00702A61N 1/36117A61N 5/00A61B 2018/00577A61B 2018/00779A61B 2018/00267A61B 2018/00875
59
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods and apparatus are provided for renal neuromodulation using a pulsed electric field to effectuate electroporation or electrofusion. It is expected that renal neuromodulation (e.g., denervation) may, among other things, reduce expansion of an acute myocardial infarction, reduce or prevent the onset of morphological changes that are affiliated with congestive heart failure, and/or be efficacious in the treatment of end stage renal disease. Embodiments of the present invention are configured for extravascular delivery of pulsed electric fields to achieve such neuromodulation.
Claims
exact text as granted — not AI-modified1 - 65 . (canceled)
66 . A method for treating a patient diagnosed with chronic heart failure, the method comprising:
extravascularly positioning an energy transfer element carried by a catheter adjacent to renal nerves innervating a kidney of the patient; and ablating the renal nerves innervating the kidney via energy from the energy transfer element, wherein ablating the renal nerves therapeutically treats the diagnosed chronic heart failure of the patient.
67 . The method of claim 66 wherein ablating the renal nerves innervating the kidney reduces central sympathetic drive in the patient in a manner that therapeutically treats the diagnosed chronic heart failure.
68 . The method of claim 66 wherein ablating the renal nerves innervating the kidney via energy from the energy transfer element comprises delivering radio frequency (RF) energy in a monopolar fashion between the energy transfer element and an external ground pad attached to an exterior of the patient.
69 . The method of claim 66 wherein the catheter comprises a plurality of energy transfer elements, and wherein ablating the renal nerves innervating the kidney via energy from the energy transfer element comprises delivering radio frequency (RF) energy in a bipolar fashion between two or more of the energy transfer elements.
70 . The method of claim 66 wherein the catheter comprises a plurality of energy transfer elements, and wherein the individual energy transfer elements are dynamically assignable.
71 . The method of claim 66 wherein ablating the renal nerves innervating the kidney via energy from the energy transfer element comprises ablating afferent renal nerves of the patient via RF energy from the energy transfer element.
72 . The method of claim 66 wherein ablating the renal nerves innervating the kidney via energy from the energy transfer element comprises ablating both afferent and efferent renal nerves of the patient via RF energy from the energy transfer element.
73 . The method of claim 66 wherein extravascularly positioning an energy transfer element carried by a catheter adjacent to renal nerves comprises positioning the energy transfer element at or near a renal hilum of the patient.
74 . The method of claim 66 wherein extravascularly positioning an energy transfer element carried by a catheter adjacent to renal nerves comprises positioning the energy transfer element along a renal vein of the patient.
75 . The method of claim 66 wherein extravascularly positioning an energy transfer element carried by a catheter adjacent to renal nerves comprises delivering the catheter over a guidewire.
76 . The method of claim 66 wherein ablating the renal nerves innervating the kidney comprises at least partially denervating the kidney of the patient.
77 . The method of claim 66 , further comprising monitoring a parameter of the energy transfer element and/or tissue within the patient before and during delivery of energy via the energy transfer element.
78 . The method of claim 77 wherein monitoring a parameter comprises monitoring power, temperature, and/or impedance.
79 . The method of claim 77 wherein monitoring a parameter comprises monitoring at least one physiological parameter of the patient.
80 . The method of claim 79 wherein the monitored physiological parameter comprises plasma renin levels and/or other neurohormones that are indicative of increased sympathetic nervous activity of the patient.
81 . The method of claim 67 , further comprising varying delivery of the energy via the energy transfer element in response to the monitored parameter.
82 . The method of claim 66 wherein extravascularly positioning an energy transfer element carried by a catheter comprises delivering a distal segment of the catheter within a probe, and wherein the method further comprises at least partially extending the distal segment of the catheter out from the probe before delivering energy via the energy transfer element.
83 . The method of claim 66 , further comprising removing the catheter from the patient after delivering the energy to conclude the procedure.
84 . The method of claim 83 wherein extravascularly positioning an energy transfer element carried by a catheter adjacent to renal nerves innervating a kidney of the patient comprises positioning the energy transfer element under visual guidance.
85 . The method of claim 83 wherein extravascularly positioning an energy transfer element carried by a catheter adjacent to renal nerves innervating a kidney of the patient comprises extravascularly positioning the energy transfer element under guidance chosen from the group consisting of computed tomographic, radiographic, ultrasonic, angiographic, laparoscopic and combinations thereof.Join the waitlist — get patent alerts
Track US2019282816A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.